Benjamin H Freed1, Vistasp Daruwalla1, Jeanette Y Cheng1, Frank G Aguilar1, Lauren Beussink1, Andrew Choi1, David A Klein1, Debra Dixon1, Abigail Baldridge1, Laura J Rasmussen-Torvik1, Kameswari Maganti1, Sanjiv J Shah2. 1. From the Division of Cardiology, Department of Medicine (B.H.F., V.D., J.Y.C., F.G.A., L.B., A.C., D.A.K., D.D., K.M., S.J.S.) and the Department of Preventive Medicine (A.B., L.J.R.-T.), Northwestern University Feinberg School of Medicine, Chicago, IL. 2. From the Division of Cardiology, Department of Medicine (B.H.F., V.D., J.Y.C., F.G.A., L.B., A.C., D.A.K., D.D., K.M., S.J.S.) and the Department of Preventive Medicine (A.B., L.J.R.-T.), Northwestern University Feinberg School of Medicine, Chicago, IL. sanjiv.shah@northwestern.edu.
Abstract
BACKGROUND: Left atrial (LA) enlargement is associated with adverse events in heart failure with preserved ejection fraction (HFpEF). However, the role of LA mechanics (ie, LA strain measures) in HFpEF has not been well studied. We hypothesized that in HFpEF, reduced (worse) LA strain is a key pathophysiologic abnormality and is a stronger correlate of adverse events than left ventricular or right ventricular longitudinal strain. METHODS AND RESULTS: We evaluated baseline LA function in 308 patients with HFpEF who were followed up longitudinally for adverse outcomes. All patients underwent speckle-tracking echocardiography for measurement of left ventricular longitudinal strain, right ventricular free wall strain, and LA booster, conduit, and reservoir strains. The clinical and prognostic significance of left ventricular, right ventricular, and LA strain measures was assessed by regression analyses. The mean age was 65±13 years, 64% were women, 26% had atrial fibrillation, and LA enlargement was present in the majority of patients (67%). Decreased LA reservoir strain was associated with increased pulmonary vascular resistance (P<0.0001) and decreased peak oxygen consumption (P=0.0001). Of the left ventricular, right ventricular, and LA strain measures, LA reservoir strain was the strongest correlate of adverse events and was independently associated with the composite outcome of cardiovascular hospitalization or death (adjusted hazard ratio per 1-SD decrease in LA strain, 1.54; 95% CI, 1.15-2.07; P=0.006). CONCLUSIONS: Abnormal indices of LA mechanics (particularly LA reservoir strain) are powerful clinical and prognostic factors in HFpEF. Unloading the LA and augmentation of LA function may be important future therapeutic targets in HFpEF. REGISTRATION INFORMATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01030991.
BACKGROUND:Left atrial (LA) enlargement is associated with adverse events in heart failure with preserved ejection fraction (HFpEF). However, the role of LA mechanics (ie, LA strain measures) in HFpEF has not been well studied. We hypothesized that in HFpEF, reduced (worse) LA strain is a key pathophysiologic abnormality and is a stronger correlate of adverse events than left ventricular or right ventricular longitudinal strain. METHODS AND RESULTS: We evaluated baseline LA function in 308 patients with HFpEF who were followed up longitudinally for adverse outcomes. All patients underwent speckle-tracking echocardiography for measurement of left ventricular longitudinal strain, right ventricular free wall strain, and LA booster, conduit, and reservoir strains. The clinical and prognostic significance of left ventricular, right ventricular, and LA strain measures was assessed by regression analyses. The mean age was 65±13 years, 64% were women, 26% had atrial fibrillation, and LA enlargement was present in the majority of patients (67%). Decreased LA reservoir strain was associated with increased pulmonary vascular resistance (P<0.0001) and decreased peak oxygen consumption (P=0.0001). Of the left ventricular, right ventricular, and LA strain measures, LA reservoir strain was the strongest correlate of adverse events and was independently associated with the composite outcome of cardiovascular hospitalization or death (adjusted hazard ratio per 1-SD decrease in LA strain, 1.54; 95% CI, 1.15-2.07; P=0.006). CONCLUSIONS: Abnormal indices of LA mechanics (particularly LA reservoir strain) are powerful clinical and prognostic factors in HFpEF. Unloading the LA and augmentation of LA function may be important future therapeutic targets in HFpEF. REGISTRATION INFORMATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01030991.
Authors: Vojtech Melenovsky; Barry A Borlaug; Boaz Rosen; Ilan Hay; Luigi Ferruci; Christopher H Morell; Edward G Lakatta; Samer S Najjar; David A Kass Journal: J Am Coll Cardiol Date: 2006-12-29 Impact factor: 24.094
Authors: Rita Vianna-Pinton; Carlos A Moreno; Christy M Baxter; Kwan S Lee; Teresa S M Tsang; Christopher P Appleton Journal: J Am Soc Echocardiogr Date: 2009-03 Impact factor: 5.251
Authors: Roberto M Saraiva; Sayit Demirkol; Adisai Buakhamsri; Neil Greenberg; Zoran B Popović; James D Thomas; Allan L Klein Journal: J Am Soc Echocardiogr Date: 2010-02 Impact factor: 5.251
Authors: Yasuhiko Takemoto; Marion E Barnes; James B Seward; Steven J Lester; Christopher A Appleton; Bernard J Gersh; Kent R Bailey; Teresa S M Tsang Journal: Am J Cardiol Date: 2005-09-15 Impact factor: 2.778
Authors: Suman S Kuppahally; Nazem Akoum; Nathan S Burgon; Troy J Badger; Eugene G Kholmovski; Sathya Vijayakumar; Swati N Rao; Joshua Blauer; Eric N Fish; Edward V R Dibella; Rob S Macleod; Christopher McGann; Sheldon E Litwin; Nassir F Marrouche Journal: Circ Cardiovasc Imaging Date: 2010-02-04 Impact factor: 7.792
Authors: Walter P Abhayaratna; Kaniz Fatema; Marion E Barnes; James B Seward; Bernard J Gersh; Kent R Bailey; Grace Casaclang-Verzosa; Teresa S M Tsang Journal: Am J Cardiol Date: 2008-04-18 Impact factor: 2.778
Authors: Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert Journal: Eur Heart J Date: 2007-04-11 Impact factor: 29.983
Authors: Jacob A Burns; Cynthia Sanchez; Lauren Beussink; Vistasp Daruwalla; Benjamin H Freed; Senthil Selvaraj; Sanjiv J Shah Journal: Am J Cardiol Date: 2018-07-19 Impact factor: 2.778
Authors: Maximilian von Roeder; Johannes Tammo Kowallick; Karl-Philipp Rommel; Stephan Blazek; Christian Besler; Karl Fengler; Joachim Lotz; Gerd Hasenfuß; Christian Lücke; Matthias Gutberlet; Holger Thiele; Andreas Schuster; Philipp Lurz Journal: Clin Res Cardiol Date: 2019-05-03 Impact factor: 5.460